Blood group AB and factor V Leiden as risk factors for pre-eclampsia: A population-based nested case-control study

Thrombosis Research

Volumn 124, Issue 2, 2009, Pages 167-173

  Hiltunen, Leena M ^a   Laivuori, Hannele ^b,c   Rautanen, Anna ^d   Kaaja, Risto ^c   Kere, Juha ^b,e   Krusius, Tom ^a   Paunio, Mikko ^d   Rasi, Vesa ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b BIOMEDICUM HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

ABO blood group; Factor V Leiden; FII G20210A; Pre eclampsia; Pregnancy; Thrombophilia

Indexed keywords

BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN ANTIBODY;

ADULT; ARTICLE; BLOOD GROUP AB; BLOOD GROUP ABO SYSTEM; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FINLAND; GENETIC POLYMORPHISM; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; POPULATION BASED CASE CONTROL STUDY; PREECLAMPSIA; PREGNANCY; PRIMIGRAVIDA; PRIORITY JOURNAL; REGISTER; THROMBOPHILIA; TWIN PREGNANCY;

ADOLESCENT; ADULT; BLOOD GROUP ANTIGENS; CASE-CONTROL STUDIES; FACTOR V; FEMALE; FINLAND; HUMANS; ODDS RATIO; POPULATION GROUPS; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; YOUNG ADULT;

EID: 67249114711     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.11.012     Document Type: Article

References (46)

1. Silva L.M., Coolman M., Steegers E.A.P., Jaddoe V.W.V., Moll H.A., Hofman A., et al. Low socioeconomic status is a risk factor for preeclampsia: the Generation R Study. J Hypertens 26 (2008) 1200-1208
2. Clark P., Walker I.D., Govan L., Wu O., and Greer I.A. The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes. Br J Haematol 140 (2008) 236-240
3. Villar J., Carroli G., Wojdyla D., Abalos E., Giordano D., Ba'aqeel H., et al. the World Health Organization Antenatal Care Trial Research Group. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?. Am J Obstet Gynecol 194 (2006) 921-931
4. Klemmensen Å.K., Olsen S.F., Østerdal M.L., and Tabor A. Validity of preeclampsia-related diagnoses recorded in a national hospital registry and in a postpartum interview of the women. Am J Epidemiol 166 (2007) 117-124
5. Roberts C.L., Algert C.S., Morris J.M., Ford J.B., and Henderson-Smart D.J. Hypertensive disorders in pregnancy: a population-based study. MJA 182 (2005) 332-335
6. Lie R.T., Rasmussen S., Brunborg H., Gjessing H.K., Lie-Nielsen E., and Irgens L.M. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 316 (1998) 1343-1347
7. Hauth J.C., Ewell M.G., Levine R.J., Esterlitz J.R., Sibai B., Curet L.B., et al. for the Calcium for Preeclampsia Prevention Study Group. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol 95 (2000) 24-28
8. Lewis G. Introduction and key findings 2000-2002. In: Lewis G. (Ed). Why mothers die 2000-2002 (2004), RCOG Press, London 25-58
9. Sibai B., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785-799
10. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., and McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161 (1989) 1200-1204
11. Ness R.B., and Roberts J.M. Heterogeneous causes constituting the single syndrome of pre-eclampsia: a hypothesis and its implications. Am J Obstet Gynecol 175 (1996) 1365-1370
12. Rodie V.A., Freeman D.J., Sattar N., and Greer I.A. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?. Atherosclerosis 175 (2004) 189-202
13. Jick H., Slone D., Westerholm B., Inman W.H.W., Vessey M.P., Shapiro S., et al. Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet 1 7594 (1969) 539-542
14. Larsen T.B., Johnsen S.P., Gislum M., Møller C.A.I., Larsen H., and Sørensen H.T. ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study. J Thromb Haemost 3 (2005) 300-304
15. Morelli V.M., De Visser M.C.H., Vos H.L., Bertina R.M., and Rosendaal F.R. ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J Thromb Haemost 3 (2005) 183-185
16. von Beckerath N., Koch W., Mehilli J., Gorchakova O., Braun S., Schomig A., et al. ABO locus O1 allele and risk of myocardial infarction. Blood Coagul Fibrinolysis 15 (2004) 61-67
17. May D. Maternal blood group A and pre-eclampsia. Br Med J 4 5894 (1973) 738
18. Spinillo A., Capuzzo E., Baltaro F., Piazzi G., and Iasci A. Case-control study of maternal blood group and severe pre-eclampsia. J Hum Hypertens 9 (1995) 623-625
19. Lin J., and August P. Genetic thrombophilias and pre-eclampsia: a meta-analysis. Obstet Gynecol 105 (2005) 182-192
20. Robertson L., Wu O., Langhorne P., Twaddle S., Clark P., Lowe G.D.O., et al. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 132 (2006) 171-196
21. Nurk E., Tell G.S., Refsum H., Ueland P.M., and Vollset S.E. Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. Q J Med 99 (2006) 289-298
22. Morrison E.R., Miedzybrodzka Z.H., Campbell D.M., Haites N.E., Wilson B.J., Watson M.S., et al. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematical review. Thromb Haemost 87 (2002) 779-785
23. Hannaford P., Ferry S., and Hirsch S. Cardiovascular sequlae of toxaemia of pregnancy. Heart 77 (1997) 154-158
24. Bertina R.M., Koeleman B.P.C., Koster T., Rosendaal F.R., Dirven R.J., de Ronde H., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 (1994) 64-67
25. Lunghi B., Iacoviello L., Gemmati D., Dilasio M.G., Castoldi E., Pinotti M., et al. Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma. Thromb Haemost 75 (1996) 45-48
26. Poort S.R., Rosendaal F.R., Reitsma P.H., and Bertina R.M. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88 (1996) 3698-3703
27. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Mathews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
28. Levo A., Kuismanen K., Holopainen P., Vahtera E., Rasi V., Krusius T., et al. Single founder mutation (W380G) in type II protein C deficiency in Finland. Thromb Haemost 84 (2000) 424-428
29. Kleesiek K., Schmidt M., Götting C., Brinkmann T., and Prohaska W. A first mutation in the human tissue factor pathway inhibitor gene encoding [P151 L]TFPI. Blood 92 (1998) 3976-3977
30. Mikkola H., Syrjälä M., Rasi V., Vahtera E., Hämäläinen E., Peltonen L., et al. Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 84 (1994) 517-525
31. Francis C.W. Factor XIII polymorphisms and venous thromboembolism. Arch Pathol Lab Med 126 (2002) 1391-1393
32. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
33. Callaghan W.M. Invited Commentary: Identifying women with hypertension during pregnancy - is high specificity sufficient?. Am J Epidemiol 166 (2007) 125-127
34. ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 99 (2002) 159-167
35. Hiltunen L., Rautanen A., Rasi V., Kaaja R., Kere J., Krusius T., et al. An unfavourable combination of factor V Leiden with age, weight, and blood group causes high risk of pregnancy-associated venous thrombosis - a population-based nested case-control study. Thromb Res 119 (2007) 423-432
36. Ødegård R.A., Vatten L.J., Nilsen S.T., Salvesen K.Å., and Austgulen R. Risk factors and clinical manifestations of pre-eclampsia. BJOG 107 (2000) 1410-1416
37. Tuffnell D.J., Jankowicz D., Lindow S.W., Lyons G., Mason G.C., Russell I.F., et al. On behalf of the Yorkshire Obstetric Critical Care Group (2005). Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003. BJOG (2005) 112:8875-80
38. Waterstone M., Bewley S., and Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMI 322 (2001) 1089-1094
39. Magnussen E.B., Vatten L.J., Lund-Nilsen T.I., Salvesen K.Å., Smith G.D., and Romundstad P.R. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ 335 (2007) 978-981
40. Hoff C., and Bixler C. Maternofetal ABO antigenic dissimilarity and pre-eclampsia. Lancet 1 8379 (1984) 729-730
41. Witsenburg C.P.J., Rosendaal F.R., Middeldorp J.M., Van der Meer F.J.M., and Scherjon S.A. Factor VIII levels and the risk of pre-eclampsia, HELLP syndrome, pregnancy related hypertension and severe intrauterine growth retardation. Thromb Res 115 (2005) 387-392
42. Laivuori H., Lahermo P., Ollikainen V., Widen E., Häivä-Mällinen L., Sundström H., et al. Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Genet 72 (2003) 168-177
43. Dudding T.E., and Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemost 91 (2004) 700-711
44. Laivuori H., Kaaja R., Ylikorkala O., Hiltunen T., and Kontula K. &77 C->T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia. Obstet Gynecol 96 (2000) 277-280
45. Jääskeläinen E., Keski-Nisula L., Toivonen S., Romppanen E.L., Helisalmi S., Punnonen K., et al. MTHFR C677T polymorphism is not associated with placental abruption or preeclampsia in Finnish women. Hypertens Pregnancy 25 (2006) 73-80
46. Clark P., Freeman D.J., Streja E., Sattar N., Walker I.D., and Greer I.A. The G-to-T point mutation in codon 34 of the factor XIII gene and the risk of pre-eclampsia. Blood Coagul Fibrinolysis 14 (2003) 155-157